The Effect of Melissa Officinalis Capsules and Health Care Educational Program on the Severity of the Symptoms of Premenstrual Syndrome
- Conditions
- Premensstural Syndrom.Premenstrual tension syndrome
- Registration Number
- IRCT2014060717998N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 800
willingness to participate in the study, obtaining informed consent from the parents of the students, not being in any stressful situation at the time of enrollment or during the study, presence in the educational sessions, not consuming vitamin supplements at the time of enrollment, not consuming hormonal medications such as contraceptives for at least 2 months before or during the study, a menstrual period of 3 to 7 days, lack of any underlying diseases such as thyroid diseases, diabetes mellitus and psychiatric disease. Exclusion criteria: the children’s willingness to leave the study, the request of the parents for exclusion of their children from the study, occurrence of a stressful event for the students or their parents during the study, absence of more than 2 sessions in group interactions and not compensating for missed sessions by participating in the sessions of other groups, consuming any medications during the study, any changes in the menstrual period (less than 3 days and more than 7 days), any changes in menstrual cycle length (less than 24 days and more than 35 days) and having stress during the study or in the last 3 months (such as death of the relatives, marriage or undergoing any surgical procedure).
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mental and emotional symptoms of premenstrual syndrome. Timepoint: In the second step before the intervention and at the end of each month after the intervention (for 3 months). Method of measurement: Premenstrual Syndrome Screening Questionnaire.;Physical symptoms of premenstrual syndrome. Timepoint: In the second step before the intervention and at the end of each month after the intervention (for 3 months. Method of measurement: Premenstrual Syndrome Screening Questionnaire.
- Secondary Outcome Measures
Name Time Method Individual's general health especially mental health. Timepoint: Before the intervention. Method of measurement: General Health Questionnaire (G.H.Q).